Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study170
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?66
24
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study20
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders19
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System19
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation19
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries18
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry17
The Mini-TRH Test15
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety15
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study13
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?12
12
Predicting mental health symptoms with NBS-Predict12
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA11
11
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen11
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS9
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response8
News on the Role of Antidepressants in and for COVID-19 and Long COVID8
8
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation8
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey7
Patient and Physician Exposure to Artificial Intelligence Hype7
7
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes6
Impaired nonverbal communication is associated with symptom severity in Depression6
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie6
6
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches5
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab5
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials5
Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis5
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita5
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use5
5
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis5
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review4
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye4
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs4
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?4
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell4
4
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics4
Overview: Chronic Pain and Cannabis-Based Medicines4
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality3
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality3
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa3
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges3
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation3
Metformin is Protective Against the Development of Mood Disorders3
0.52887392044067